Abstract:High-mobility group box 1 protein (HMGB1) is a chromatin protein and acts as a cytokine involved in inflammation, cell proliferation, differentiation, migration and stem cell recruitment. So far, little is known about its effect on hematopoietic stem cells (HSCs). In this study, we investigated whether receptors for HMGB1 are expressed on human CD34+ HSCs, and whether HMGB1 could affect HSCs proliferation, differentiation and migration in vitro. As examined by FACS analysis and RT-PCR, cord blood CD34+ HSCs express the HMGB1 receptors RAGE (receptor for advanced glycation end products), TLR2 (Toll-like receptor 2) and TLR4. To study the effects of HMGB1 on CD34+ HSCs proliferation and differentiation, freshly isolated cord blood CD34+ HSCs were cultured for 7 days in medium alone or in the presence of HMGB1. Flow cytometric analysis showed that HMGB1 (50ng/ml) can induce the differentiation of CD34+ HSCs along the granulo-monocytic (CD14+, CD13+) lineage and erythropoiesis (CD71+). In contrast, HMGB1 did not induce the expression of CD41, a marker for megakaryocyte lineage. The numbers of cells cultured in the presence of HMGB1 were always increased in comparison with controls. Furthermore, higher numbers of granulomonocytic progenitors (CFU-GM), erythroid progenitors (BFU-E), and CFU-MIX were confirmed by CFC assays in a HMGB1 dose dependent manner after 14-day culture. The results suggest that HMGB1 enhances CD34+ HSCs proliferation and differentiation. We next assessed the effects of HMGB1 on HSCs migration by chemotaxis assay using Boyden chambers. HMGB1 dose-dependently increased the chemotactic migration of CD34+ HSCs. A neutralizing anti-RAGE antibody significantly blocked the HMGB1-induced migration of HSCs, whereas neutralizing TLR2 and TLR4 antibodies did not significantly influence HMGB1-stimulated HSCs migration, suggesting that the migratory effect of HMGB1 on human HSCs is predominantly mediated by RAGE. In summary, our results provide the first report of HMGB1 receptors expression profile of human cord blood CD34+ HSCs and demonstrate that HMGB1 can increase the proliferation and migration of HSCs and directly induce of HSCs along myeloid differentiation and erythropoiesis in vitro. Further studies will be needed to clarify the mechanism of HMGB1 activation and the physiological function of HMGB1 in HSCs in vivo.

Effect of vasoactive intestinal polypeptide on proliferation and differentiation of human CD34~+ cells derived from cord blood

Initial Research for Effects of Vasoactive Intestinal Polypeptide(VIP) on Differentiation of Human Umbilical Cord Blood Derived CD34+ Cells into Hepatic Related Cells

Vasoactive Intestinal Polypeptide Suppresses Proliferation of Human Cord Blood-Derived Hematopoietic Progenitor Cells by Increasing TNF-α and TGF-β Production in the Liver

Preferential expression of the vasoactive intestinal peptide (VIP) receptor VPAC1 in human cord blood-derived CD34+CD38− cells: possible role of VIP as a growth-promoting factor for hematopoietic stem/progenitor cells

Effects of Vasoactive Intestinal Peptide on Phenotypic and Functional Maturation of Dendritic Cells

Effect of PolyI:C on Quantity and Activity of Endothelial Progenitor Cells from Human Umbilical Cord Blood

[Effects of Vascular Endothelial Growth Factor on Differentiation and Function of Dendritic Cells Generated from CD34+ Hematopoietic Progenitor Cells in Vitro].

Vascular endothelial growth factor on function of endothelial progenitor cells from peripheral blood

Effects of Somatostatin on Proliferation Ability of Human CD34+ Cells Derived from Umbilical Cord Blood

Effects of many kinds of cytokines on CD34+ cell proliferation and differentiation

The effect of vasoactive intestinal peptide on CD80 and CD86 expression in MKN45 tumor-burdened nude mice

Extracellular HMGB1 Enhances Proliferation, Differentiation and Migration of Human CD34+ Hematopoietic Stem Cells in Vitro

[Influence of Cytokine Combinations on Proliferation and Differentiation of Umbilical Cord Blood CD34(+) Cells into Megakaryocytes/platelets in Vitro].

[Activation of Signal Transducers and Activators of Transcription Induced by Vascular Endothelial Growth Factor in CD34+ Hematopoietic Progenitor Cells in Vitro].

Effect of VCAM-1 Modified Human Umbilical Cord Blood Stromal Cells on Expansion of Hematopoietic Stem/progenitor Cells

Study on Influence of the Homing Related Molecules on Umbilical Cord Blood CD34+ Cells after Amplified with Cytokines in Vitro

In Vitro Studies on Effects of Adhesion Molecular and Hematopoietic Growth Factors on Transendothelial Migration of Cord Blood Hematopoietic Stem/progenitor Cells

Advance on Vasoactive Intestinal Peptide Regulating Lymphocyte Differentiation

[Effect of TGF-beta1 on biological characteristics of umbilical cord blood hematopoietic progenitor cells during ex-vivo expansion].

Effect of Resveratrol on Proliferation and Differentiation of Endothelial Progenitor Cells from Peripheral Blood in Vitro

Study Of In Vitro Proliferation Potential Of Cd133 Positive Cells Derived From Umbilical Cord Blood